drugs and medicines well work against one group of microbes can't work against another group of Microbes why
Answers
Answer:
ABSTRACT
Bacteria and viruses are not always categorized as harmful microorganisms. In fact, these groups of microbes can be beneficial and can actively participate in many biological processes. With the perception of microorganisms being our partners, research is now being conducted to use microbes to treat disease and enhance human health. Some viruses and species of bacteria can be targeted to kill cancer cells while others can be deployed to replicate in and kill tumors. The Academy convened a colloquium in April 2014 in San Diego, CA to discuss the vast potential of microbes as supplements to existing therapies against infectious and chronic diseases. The product of those discussions was the full report, Harnessing the Power of Microbes as Therapeutics: Bugs as Drugs
Explanation:
marl it brilliant
Explanation:
Bacteria and viruses are not always categorized as harmful microorganisms. In fact, these groups of microbes can be beneficial and can actively participate in many biological processes. With the perception of microorganisms being our partners, research is now being conducted to use microbes to treat disease and enhance human health. Some viruses and species of bacteria can be targeted to kill cancer cells while others can be deployed to replicate in and kill tumors. The Academy convened a colloquium in April 2014 in San Diego, CA to discuss the vast potential of microbes as supplements to existing therapies against infectious and chronic diseases. The product of those discussions was the full report, Harnessing the Power of Microbes as Therapeutics: Bugs as Drugs.
Front Matter
The American Academy of Microbiology (Academy) is the honorific branch of the American Society for Microbiology (ASM), a non-profit scientific society with nearly 40,000 members. Fellows of the Academy have been elected by their peers in recognition of their outstanding contributions to the field of microbiology. Through its colloquium program, the Academy draws on the expertise of these fellows to address critical issues in microbiology.
This report is based on the deliberations of experts who gathered for two days to discuss a series of questions developed by the steering committee regarding the use of microorganisms as therapeutic agents. This report has been reviewed by the majority of participants, and every effort has been made to ensure that the information is accurate and complete. The contents reflect the views of the participants and are not intended to reflect official positions of the Academy or ASM. The Academy thanks the efforts of previous staff, Leah Gibbons and Shannon Greene, Ph.D., for their assistance on this project.
Contents of the report may be distributed further so long as the authorship of the Academy is acknowledged and this disclaimer is included.